N-cadherin stabilises neural identity by dampening anti-neural signals by Punovuori, Anna et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-cadherin stabilises neural identity by dampening anti-neural
signals
Citation for published version:
Punovuori, A, Migueles, RP, Malaguti, M, Blin, G, MacLeod, KG, Carragher, N, Pieters, T, van Roy, F,
Stemmler, MP & Lowell, S 2019, 'N-cadherin stabilises neural identity by dampening anti-neural signals',
Development. https://doi.org/10.1242/dev.183269
Digital Object Identifier (DOI):
10.1242/dev.183269
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Development
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
© 2019. Published by The Company of Biologists Ltd. 
 
 
N-cadherin stabilises neural identity by dampening anti-neural signals 
 
Punovuori K1, Migueles RP1, Malaguti M1, Blin G1, Macleod KG2, Carragher NO2, Pieters T3, van Roy 
F4, Stemmler MP5, Lowell S1,*. 
 
 
1 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological 
Sciences, The University of Edinburgh, Edinburgh. 
2 Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, 
University of Edinburgh, Edinburgh, UK. 
3 Department of Biomedical Molecular Biology, Ghent University; Inflammation Research Center, 
VIB; Center for Medical Genetics, Ghent University Hospital; Cancer Research Institute Ghent (CRIG) 
4 Department of Biomedical Molecular Biology, Ghent University; Inflammation Research Center, 
VIB; Cancer Research Institute Ghent (CRIG).  
5 Department of Experimental Medicine I, Nikolaus-Fiebiger Center for Molecular Medicine, 
Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. 
 
*Author for correspondence: sally.lowell@ed.ac.uk 
 
 
 
 
 
  
  
D
ev
el
o
pm
en
t •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
http://dev.biologists.org/lookup/doi/10.1242/dev.183269Access the most recent version at 
First posted online on 10 October 2019 as 10.1242/dev.183269
 Abstract  
 
A switch from E- to N-cadherin regulates the transition from pluripotency to neural identity, but the 
mechanism by which cadherins regulate differentiation was previously unknown. Here we show that 
the acquisition of N-cadherin stabilises neural identity by dampening anti-neural signals. We use 
quantitative image-analysis to identify an effect of N-cadherin to promote neural differentiation 
independently of effects on cell cohesiveness. We reveal that cadherin switching diminishes the level 
of nuclear β-catenin, and that N-cadherin also dampens FGF activity and consequently stabilises 
neural fate. Finally, we compare the timing of cadherin switching and differentiation in vivo and in 
vitro, and find that this process becomes dysregulated during in vitro differentiation. We propose 
that N-cadherin helps to propagate a stable neural identity throughout the emerging 
neuroepithelium, and that dysregulation of this process contributes to asynchronous differentiation 
in culture. 
 
 
Introduction 
 
There is an increasing appreciation that changes in adhesion and morphology help to 
regulate cell fate changes (Gilmour et al., 2017). The homotypic adhesion molecule E-cadherin is 
expressed on the surface of pluripotent cells and is downregulated and replaced with N-cadherin 
during early neural development (Hatta and Takeichi, 1986; Wheelock et al., 2008). We previously 
reported that loss of E-cadherin is not simply a consequence of differentiation, but rather that it 
actively promotes the neural differentiation process (Malaguti et al., 2013). However the role of N-
cadherin in this process and the mechanisms by which cadherins regulate neural differentiation are 
not known. 
It has previously been reported that premature cadherin switching has profound effects at 
gastrulation, including an expansion of the extraembryonic compartment, a reduction in the size of 
the epiblast, and mis-patterning of the germ layers (Basilicata et al., 2016). These diverse 
phenotypes can be attributed at least in part to an overall reduction in BMP signalling within the 
epiblast and a reduction in pro-mesoderm signals at the primitive streak, which in turn may result 
from the gross morphological defects seen in these embryos (Basilicata et al., 2016). However it is 
not clear which aspects of this complex phenotype are an indirect consequence of defects in 
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extraembryonic tissues and which, if any, are cell-autonomous. Here we use cultured mouse 
pluripotent cells in order to focus on the mechanism by which cadherin switching influences neural 
differentiation of pluripotent cells in the absence of extraembryonic tissues. 
Mouse pluripotent cells can be cultured in the presence of inhibitors of MEK and Gsk3β plus 
LIF (2i+LIF) in order to maintain them in a naïve embryonic stem cell (ESC) state equivalent to the 
preimplantation epiblast (Boroviak et al., 2015; Ying et al., 2008), or they can be cultured in the 
presence of FGF and Activin in order to maintain a differentiation-primed epiblast stem cell (EpiSC) 
state equivalent to the postimplantation epiblast (Brons et al., 2007; Nichols and Smith, 2009; Tesar 
et al., 2007). LIF and foetal calf serum (FCS) support a heterogeneous mixture of pluripotent cells 
moving in and out of the naïve state. We previously reported that cells downregulate E-cadherin 
during neural differentiation of ES cells, and that loss of E-cadherin leads to faster, more 
synchronous neural differentiation in vitro (Malaguti et al., 2013), in keeping with other reports that 
E-cadherin acts as a 'brake' to slow down differentiation of pluripotent cells (Chou et al., 2008; del 
Valle et al., 2013; Faunes et al., 2013; Livigni et al., 2013; Redmer et al., 2011; Soncin et al., 2009). E-
cadherin-null ESCs display a loss of cell-cell adhesion (Larue et al., 1994; Larue et al., 1996), raising 
the possibility that their neural differentiation phenotype may be a secondary consequence of their 
adhesion defect. Alternatively, cadherins could influence differentiation by modulating signalling 
independently of adhesion (Bedzhov et al., 2012; del Valle et al., 2013; Wheelock et al., 2008; Zhang 
et al., 2010). 
Neural specification depends on inhibition of BMP and Nodal signalling (Camus et al., 2006; 
Di-Gregorio et al., 2007). The ability of BMP to block neural fate is at least in part due to 
maintenance of E-cadherin expression, but it is not know which signalling pathways act downstream 
of cadherins to modulate differentiation. Dampening of either FGF (Greber et al., 2010; Jaeger et al., 
2011; Stavridis et al., 2010; Sterneckert et al., 2010) or Wnt (Aubert et al., 2002; Haegele et al., 2003) 
has the effect of stabilising neural identity. N-cadherin has been reported to modulate FGF activity 
(Takehara et al., 2015; Utton et al., 2001; Williams et al., 1994; Williams et al., 2001) and E-cadherin 
has been reported to modulate Wnt activity in other contexts (Howard et al., 2011), and so it seems 
plausible that cadherin switching may modulate neural differentiation via dampening of one or both 
of these anti-neural signalling pathways. Alternatively, it is possible that cadherins modulate other 
signalling pathways (Pieters and van Roy, 2014). 
Here, we set out to ask how the switch from E-cadherin to N-cadherin influences 
differentiation. We present evidence that N-cadherin promotes neural differentiation by dampening 
FGF activity. We also discover that cadherin switching occurs later and more synchronously during 
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anterior neural differentiation in vivo compared with neural differentiation in culture. We suggest 
that cadherins could mediate a 'community effect' by helping to propagate differentiation decisions 
to neighbouring cells, and that this may help to ensure synchronous neural commitment in the 
embryo. This effect partly breaks down in culture, helping to explain why differentiation in culture is 
relatively asynchronous even in the face of a uniform extrinsic environment.  
  
Results 
Cadherin switching is initiated prior to the onset of neural differentiation in vitro 
We previously reported that E-cadherin inhibits neural differentiation, but the mechanism of 
action was not known (Malaguti et al., 2013). Upregulation of N-cadherin accompanies the loss of E-
cadherin as pluripotent cells adopt a neural fate (Dady et al., 2012; Hatta and Takeichi, 1986), raising 
the possibility that N-cadherin might contribute to the regulation of the differentiation process. We 
first asked when N-cadherin becomes detectable during neural differentiation (note that we use the 
phrase 'neural differentiation' to mean the transition from pluripotency to neural identity rather 
than terminal differentiation into a particular neural derivative). 
We confirmed that mouse embryonic stem cells cultured in 2i-Lif or Lif-serum express high 
levels of E-cadherin, whereas N-cadherin mRNA and protein were undetectable in either of these 
culture conditions (Fig. 1A-B). In EpiSC culture, E-cadherin expression was heterogeneous while N-
cadherin became detectable in a subpopulation of cells (Fig. 1A-C). Cultures of EpiSCs contain 
spontaneously differentiating cells, and so we focused only on undifferentiated (Oct4+) cells (Fig. 1D, 
Fig. S1A). Almost all (99.6%) Oct4+ cells expressed E-cadherin and, of these, 13.0% also expressed N-
cadherin (Fig. 1E). Very few (<1%) Oct4+ cells expressed N-cadherin alone. These results (Fig. S1) 
show that N-cadherin becomes expressed in a subpopulation of E-cadherin+ cells prior to loss of Oct4 
expression.  
FACS analysis confirmed that the vast majority of EpiSCs express E-cadherin, but revealed 
considerable cell-to-cell variability in the levels of this adhesion molecule on the cell surface (Fig. 1C, 
red curve). This contrasted with naïve pluripotent cells, which displayed uniformly high levels of E-
cadherin throughout the population (Fig. 1C, blue curve). To further study cadherin heterogeneity in 
differentiation-primed cells, EpiSCs were sorted into three sub-populations (EcadHigh, EcadMed, and 
EcadLow)(Fig. 1F-G). EcadHigh and EcadLow populations were then analysed by qRT-PCR, normalising to 
the EcadMed population (Fig. 1H). This analysis revealed a reciprocal expression pattern between E-
cadherin and N-cadherin, consistent with an ongoing process of cadherin switching (Fig. 1H). The 
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subpopulations expressed similar levels of the general pluripotency factors Oct4 and Nanog, and the 
primed pluripotency factor Oct6, indicating no difference in their overt differentiation status (Fig. 
1H). It has been reported that differentiation-primed subpopulations of undifferentiated EpiSC 
express low levels of either the neural-priming factor Sox1 or the mesoderm-priming factor 
T/Brachyury (Tsakiridis et al., 2014). We found that the E-cadherinLow population expressed 
significantly higher levels of Sox1 and T/Brachyury, characteristic of a differentiation-primed 
subpopulation, while markers of surface ectoderm (Ap2a) or endoderm (Sox17) did not differ 
significantly between the populations (Fig. 1H).  
These results indicate that N-cadherin starts to become detectable prior to the loss of 
pluripotency transcription factors, and that a subpopulation of EpiSCs with lower E-cadherin and 
higher N-cadherin may be primed for neural and mesodermal differentiation. 
We next examined cultures at an early stage of neural differentiation (d4), where around 
50% of cells had started to adopt a neural identity, as revealed by immunostaining for Sox1-GFP 
(Ying et al., 2003), a reporter for the earliest marker of neuroepithelial identity (Wood and 
Episkopou, 1999) (Fig. 1I, Fig. S1B). In these cultures, N-cadherin was detectable in almost all Sox1-
GFP+ neural cells, and of these around half also retained E-cadherin expression. Of cells that had not 
yet acquired a Sox1-GFP+ neural identity, almost all expressed E-cadherin, and of these around 20% 
also expressed N-cadherin (Fig. 1J). 
  Taken together, these results suggest that cadherin switching is initiated prior to the onset 
of neural differentiation in vitro. 
N-cadherin promotes neural differentiation 
 Loss of E-cadherin is associated with neural differentiation of ESCs but the mechanisms by 
which cadherins might influence neural differentiation are not known (Malaguti et al., 2013). One 
possibility is that this pro-neural differentiation phenotype of cells lacking E-cadherin function may 
be a secondary consequence of their adhesion defect (Larue et al., 1994; Larue et al., 1996). If this is 
the case, then restoring adhesion should restore normal neural differentiation capacity. N-cadherin 
can rescue the E-cadherin adhesion phenotype, at least in the context of preimplantation 
development (Bedzhov et al., 2012; Kan et al., 2007). We therefore asked whether providing N-
cadherin to E-cadherin null cells would rescue their neural differentiation phenotype.  
To address this question, we made use of two E-cadherin knockout ES cell lines: Ecad-/-, 
where both cadherin alleles have been knocked out (Pieters et al., 2016), and an N-cadherin knock-in 
line EcadNcad/Ncad, in which the coding sequence of N-cadherin is knocked into the E-cadherin locus, 
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placing exogenous N-cadherin under the control of the endogenous E-cadherin regulatory elements 
and eliminating E-cadherin expression (Basilicata et al., 2016; Kan et al., 2007; Libusova et al., 
2010)(Fig. 2A). The N-cadherin knock-in (EcadNcad/Ncad) cells have been previously shown to enforce a 
cadherin switch while maintaining cell-cell adhesion in some developmental contexts (Kan et al., 
2007). Since the two lines differ in their genetic background, they are analysed side-by-side with 
their relevant control cell lines as follows: For the E-cadherin-/- cell line the control is the parental cell 
line in which the E-cadherin locus contains the loxP sites but recombination has not yet taken place 
(EcadFlox/Flox). For the E-cadherinNcad/Ncad cells the wild type control is the parental cell line in which the 
E-cadherin coding sequence is still intact (EcadWT/WT) 
We confirmed that N-cadherin was expressed above control levels in EcadNcad/Ncad cells 
throughout the course of differentiation, but was not significantly elevated above background levels 
in Ecad-/- cells (Fig 2B).  
Both Ecad-/- and EcadNcad/Ncad cells can be maintained in 2i-Lif conditions. When challenged 
with neural differentiation conditions, both cell lines were able to switch on the neural marker genes 
Sox1, Pax6 and Pax3 (Figs. 2B-D) (Pax3 is also expressed in the paraxial mesoderm, but is unlikely to 
be marking mesoderm in this context because the pan-mesodermal marker T-Brachyury is not 
upregulated above background levels in this set of experiments: Fig. S2).  Ecad-/- cells displayed a 
moderate pro-neural phenotype with some variability in neural gene expression (Fig. 2B-D). 
However, they showed greater instability than control cells, with very few cells surviving past d4 of 
neural differentiation (Fig. S3). In contrast, EcadNcad/Ncad cells exhibited a more pronounced pro-
neural phenotype, differentiating more rapidly than control cells (Fig. 2B-D). Quantification of Sox1 
expression in individual cells indicated that while Sox1 shows considerable cell-cell variability in both 
control and (to a lesser extent) Ecad-/- populations, this variability was largely eliminated in 
EcadNcad/Ncad cells, which exhibited uniformly high Sox1 expression by day 3 (Fig. 2C-D). These results 
indicated that exogenous N-cadherin reinforces rather than reverses the pro-neural phenotype of E-
cadherin-null cells.  
In order to further test whether N-cadherin contributes to promoting neural differentiation, 
we designed cell lines that allowed us to force expression of N-cadherin in the presence of 
endogenous E-cadherin. These cells, termed A2Lox-Ncad-HA cells, are engineered to enable dox-
inducible expression of an N-cadherin transgene with a C-terminal HA tag (Fig. 2E).  
When exogenous N-cadherin was induced in these cells during neural differentiation (Fig. 
2F), an increase in expression of early neural markers Sox1, Pax6 and Pax3, and an accelerated 
downregulation of the pluripotency marker Oct4 was observed (Fig. 2G). E-cadherin was also 
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downregulated more rapidly in the presence of ectopic N-cadherin, but these differences in E-
cadherin did not emerge until one day after the pro-neural phenotype first became apparent. This 
might suggest that the loss of E-cadherin is likely to be a consequence rather than a cause of 
premature neural differentiation in these experiments, although we cannot exclude the possibility 
that changes in E-cadherin contribute to the effects on differentiation in these experiments.  
Taken together, these results showed that the switch from E-cadherin to N-cadherin can 
promote neural differentiation under permissive conditions, and that the presence of N-cadherin 
contributes to this pro-neural effect.  
Pro-neural effects of N-cadherin are not explained by changes in cell cohesiveness 
 Since the primary function of cadherins is in cell-cell adhesion, we assessed whether the pro-
neural effects of cadherin switching might be a consequence of cells becoming less cohesive, i.e. 
moving further apart from one another. In culture, Ecad-/- cells are unable to form large, compact 
colonies, instead growing as small dispersed clumps of few cells (Fig 2A) (Larue et al., 1994; Larue et 
al., 1996). By contrast, N-cadherin knock-in (EcadNcad/Ncad) cells appear more similar to control cells 
(Fig. 2A) in keeping with the ability of N-cadherin to rescue the adhesion phenotype of E-cadherin 
null blastocysts (Bedzhov et al., 2012; Kan et al., 2007). However this does not exclude the possibility 
that manipulation of N-cadherin expression could have subtle effects on cell cohesion that were not 
discernible by eye nor did it exclude the possibility that adhesion or migration defects became 
apparent under differentiation conditions.  
We set out to measure whether our manipulations of cadherin expression resulted in 
changes in cell cohesiveness. We measured the inter-nuclear distances of cells (Fig. 3A) because we 
are able to perform nuclear segmentation with high accuracy (Blin et al., 2019), and because 
pluripotent and early neural cells have very scant cytoplasm, so inter-nuclear distance is a 
reasonable proxy for inter-cellular distance. This assay was designed to indirectly capture the 
consequences of any changes in adhesion or morphology, which could include a relaxation of cell-
cell contacts, an increase in cell spreading or cell volume, or an increase in migration. These 
measurements were performed in cells that had been cultured in neural differentiation conditions 
for 24 hours, a time at which cells are starting to initiate differentiation but have not yet committed 
to a neural fate (Kalkan and Smith, 2014).  
 We demonstrated that E-cadherin-null cells (Ecad-/-) had significantly greater mean inter-
nuclear edge distances than control cells at 24h under differentiation conditions (Fig. 3B-D), 
consistent with their previously-reported adhesion defect (Larue et al., 1994; Larue et al., 1996). 
Surprisingly, N-cadherin knock-in cells (EcadNcad/Ncad) also had higher mean inter-nuclear edge 
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distances from one another compared to control cells under these conditions (Fig. 3C-D). The 
number of cells present in each analysis did not differ significantly between the control and 
experimental conditions, suggesting that the observed differences in clustering were not a result of 
variable cell density (Fig. 3E). These results indicate that although N-cadherin can rescue the 
adhesion defect of E-cadherin null cells in the context of preimplantation development (Kan et al., 
2007), it cannot fully rescue effects on intercellular distances (which may result from changes in 
adhesion, migration and/or morphology) at early stages of neural differentiation in culture. These 
observations therefore do not exclude the possibility that the loss of E-cadherin influences 
differentiation partly though changes in adhesion, migration, or morphology. 
Exogenous N-cadherin can promote neural differentiation even in the presence of E-
cadherin (Fig 2G), and so we next asked whether these pro-neural effects of N-cadherin correlate 
with a change in inter-nuclear distances. When we induced N-cadherin in the presence of 
endogenous E-cadherin, inter-nuclear distances were barely affected (Fig. 3D). This alerted us to the 
possibility that the pro-neural effect of N-cadherin might not be fully explained by changes in cell 
cohesiveness, and prompted us to explore whether other mechanisms may operate. 
Loss of E-cadherin leads to the loss of global and nuclear β-catenin, but does not 
abolish WNT responsiveness  
If N-cadherin does not promote differentiation entirely through changes in cell cohesiveness, 
could it also be modulating pro-neural or anti-neural signalling pathways? This seems plausible since 
cadherins can bind various cell-surface signalling receptors and modulate signalling in other contexts 
(Bedzhov et al., 2012; Fedor-Chaiken et al., 2003; Greber et al., 2010).  
We used a reverse phase protein array (RPPA) to measure the activity of a panel of signalling 
pathways (Supplemental Table S2) and ask which of them are changed in response to cadherin 
switching. We assayed signalling pathway activity by measuring changes in the abundance of total 
protein levels and various phospho-protein species in E-cadherin null (Ecad-/-) cells and N-cadherin 
knock-in (EcadNcad/Ncad) cells compared to their respective control cell lines. All cell lines were 
cultured in neural differentiation conditions for 24 hours, a time prior to the emergence of the 
earliest neural cells that appear in response to either endogenous or experimentally-induced 
cadherin switching.  
We first confirmed that the most significant change in protein abundance in Ecad-/- and 
EcadNcad/Ncad cells was a loss of E-cadherin, as expected. The next most significant change was a 
depletion of β-catenin, whose levels were reduced by 3-fold both in Ecad-/- and EcadNcad/Ncad cells 
compared to control cells (Fig. 4A). This is in keeping with reports that β-catenin expression is 
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reduced in response to a reduction in E-cadherin in other contexts (Hendriksen et al., 2008; 
Wetering et al., 2001). Ecad-/- cells also have moderately reduced levels of PKA, AktP-Ser473 and 
AktP-Thr308, but in all cases levels of these proteins were restored to at least normal levels in 
EcadNcad/Ncad cells, making it unlikely that the pro-neural phenotype could be attributed to these 
changes in this context. We therefore focused on β-catenin as a candidate for mediating the pro-
neural effects of cadherin switching.  
Since β-catenin is a central player in the canonical WNT signalling pathway (Clevers, 2006), 
and WNT is an anti-neural signal (Aubert et al., 2002; Haegele et al., 2003), we assessed whether the 
reduced levels of β-catenin caused changes in WNT signalling responsiveness during differentiation. 
We first measured nuclear accumulation of an unphosphorylated (transcriptionally active) form of β-
catenin in response to Wnt3a (Clevers, 2006). Ecad-/-, EcadNcad/Ncad, and control cells were cultured 
for 24h in serum free media with varying concentrations of Wnt3a, and the amount of un-
phosphorylated β-catenin staining in the nucleus was then quantified. As expected, nuclear β-
catenin increased in control cells in response to increasing concentrations of Wnt3a (Figs. 4B-D). 
Strikingly, Ecad-/- and EcadNcad/Ncad cells accumulated significantly less nuclear β-catenin compared to 
WT cells even at the highest dose of Wnt3a. These results show that E-cadherin null cells display a 
dampened response to Wnt3a (at least at the level of β-catenin accumulation), and that this is not 
rescued by N-cadherin.  
We next asked whether cadherin switching allowed cells to resist the anti-neural effects of 
Wnt signalling. We first confirmed that the addition of Wnt3a suppressed neural differentiation in 
both wild type cells and Ecad-/- cells, as previously reported (Aubert et al., 2002; Haegele et al., 
2003)(Fig 4E, F). In contrast, EcadNcad/Ncad cells upregulated early neural markers even in the presence 
of high concentrations of Wnt3a, in keeping with the hypothesis that cadherin switching maintains 
neural potency by dampening Wnt signalling (Fig. 4E,F, Fig. S4).  
However, to our surprise, WNT target genes Axin2 and T/Brachyury responded to Wnt3a in 
EcadNcad/Ncad cells to a similar extent as control cell lines (Fig. 4G). This indicated that despite 
differences in global and nuclear levels of β-catenin, cells lacking E-cadherin were able to activate 
Wnt target genes normally during neural differentiation, as has been reported to be the case in 
other contexts (Wetering et al., 2001). We speculate that this could be explained if the reduced 
levels of nuclear β-catenin remain above the threshold required for an efficient transcriptional 
response.  
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 It is particularly interesting that EcadNcad/Ncad cells activated the neural marker Sox1 even in 
the presence of the anti-neural signal Wnt3a (Figs. 4E,F): this observation suggest that cadherins 
become particularly important for reinforcing differentiation in a suboptimal signalling environment. 
However, this pro-neural effect of cadherin switching did not seem to be explained by a dampening 
of Wnt-responsiveness because the transcriptional response to Wnt remains intact.  
Cadherin switching dampens FGF signalling during neural differentiation 
We next set out to ask which other signalling pathways are influenced by cadherin switching. 
Our RPPA assay indicated that a large number of proteins involved in signalling pathways were 
modulated in response to the concerted loss of E-cadherin and gain of N-cadherin (Fig. 4A). We 
previously established that exogenous N-cadherin reinforces neural differentiation (Fig 2D, Fig 4F), 
and so in order to simplify our search we decided to focus on signalling pathways than are 
modulated by N-cadherin. 
We used a Nanostring assay to focus on transcriptional readouts of a broad range of 
signalling pathways. We measured changes in signalling pathway activity 48h after inducing N-
cadherin expression during neural differentiation using our dox-inducible N-cadherin cell line (A2Lox-
Ncad-HA) as this was the time-point where the pro-neural phenotype became clearly apparent. 
Of 770 genes assayed (Supp Table S4), only a small number were upregulated in response to 
N-cadherin. These include markers of early neuroepithelial cells (Hes5: upregulated 2.4 fold, Pax3: 
upregulated 2.3 fold, Jag1: upregulated 1.5 fold,) consistent with a pro-neural effect of N-cadherin 
(Table 1). In contrast, a much larger number of genes (129 out of 142 genes at 48h post-induction) 
were significantly downregulated in response to N-cadherin overexpression. This suggests that N-
cadherin generally suppresses rather than activates transcriptional responses to signalling pathways 
in this context.  
We then assigned each of these transcriptional changes to particular signalling pathways. 
This revealed that the top three pathways modulated by N-cadherin are PI3K/Akt, Ras and MAPK: all 
of these are pathways downstream of FGF receptors (Fig. 5A). These results indicated that N-
cadherin dampens signalling pathways downstream of FGF during the early stages of neural 
differentiation, in keeping with reports that N-cadherin can interact with the FGF receptor in other 
contexts (Nguyen et al., 2016, Greber et al., 2010, Williams 1994 et al., Williams et al., 2001). 
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 N-cadherin promotes neural differentiation by dampening FGF signalling  
 We next assessed whether dampening of FGF signalling explains the pro-neural effect of 
cadherin switching.  
It has previously been reported that FGF signalling promotes the acquisition and 
maintenance of primed pluripotency, but must then be downregulated in order for primed cells to 
progress to a neural fate (Greber et al., 2010; Jaeger et al., 2011; Stavridis et al., 2010; Sterneckert et 
al., 2010). In keeping with these reports, we found that blockade of the FGFR1 receptor using 
100ng/mL of the pharmacological inhibitor PD173074 enhances the efficiency of neural 
differentiation when added at d2. Conversely, addition of 20ng/mL of FGF2 reduces expression of 
the early neural markers Sox1 and Pax6 when added at the same time-point (Figs. 5B, C).  
Having confirmed that FGF can act as an anti-neural signal in this context, we set out to test 
the hypothesis that N-cadherin promotes neural differentiation by dampening FGF responsiveness. 
In order to test this idea we asked whether boosting FGF activity was able to reverse the pro-neural 
effect of N-cadherin. 
We used dox-inducible N-cadherin (A2Lox-Ncad-HA) cells in order to induce N-cadherin 
over-expression during neural differentiation. FGF2 or the FGFR1 inhibitor PD173074 were added in 
order to modulate FGF activity. We added these reagents at d2,  the same time that dox was added 
to induce N-cadherin (Fig. 5B). We used FGF target genes Etv4 and Dusp4 to monitor FGF activity 
and demonstrated that N-cadherin dampens FGF activity during neural differentiation. We also 
observed that this effect could be at least partially rescued by addition of FGF2 (Fig. 5D). We then 
monitored neural differentiation by measuring expression of Sox1, Pax6 and Pax3. We found that 
addition of FGF2 reversed the pro-neural effects of N-cadherin, restoring the expression of these 
genes to similar levels as those seen in control cells that were undergoing differentiation in the 
absence of exogenous FGF or N-cadherin (Fig. 5D).  
We conclude that N-cadherin can promote neural differentiation by dampening FGF 
signalling. 
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 Cadherin switching and neural differentiation are more synchronous in vivo than in 
vitro 
 N-cadherin is first detectable in a subset of undifferentiated epiblast stem cells prior to 
neural differentiation (Fig. 1). Cadherin switching then proceeds progressively over several days and 
is not completed in all cells until after neural fate is established. We next asked whether cadherin 
switching also occurs asynchronously over several days during neural development in vivo.  
E-cadherin is expressed throughout the anterior epiblast during gastrulation. Although we 
were able to detect N-cadherin protein in EpiSCa, we were unable to detect this adhesion molecule 
in the anterior epiblast of mouse embryos during gastrulation. N-cadherin protein is however readily 
detectable in mesoderm that has migrated from the posterior to lie adjacent to the anterior epiblast, 
as previously reported (Radice et al., 1997)(Fig. 6A, Fig S5).  
We then focused on the newly-formed Sox1+ cells within the neural plate. We observed that 
this region uniformly displays E-cadherin but lacks detectable N-cadherin until after gastrulation (Fig. 
6A, Fig. S5). In contrast to the heterogeneity in cadherin expression observed before and during 
neural differentiation in culture (Figs. 1A, 1H), we were unable to detect any obvious local cell-to-cell 
variability in expression of either E- or N-cadherin within the epiblast or the early neuroepithelium 
(Fig. 6A). We also noticed that almost every cell expresses Sox1 in the anterior neuroepithelium in 
vivo, while in contrast only around a third of cells express Sox1 during an equivalent stage of neural 
differentiation in culture (Figs. 6B-F).  
We conclude that in the embryo, cells acquire N-cadherin after the acquisition of neural 
identity, consistent with a role in stabilising rather than inducing neural fate. We also observe that 
cadherin switching occurs relatively synchronously in vivo, in contrast with the asynchronous 
acquisition of N-cadherin in culture. Given our finding that N-cadherin can stabilise neural identity, 
this dysregulation of cadherin switching in vitro may help to explain why neural differentiation 
proceeds less synchronously in culture than in the embryo.  
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 Discussion 
  
 Here we report that the switch from E- to N-cadherin helps to reinforce neural commitment 
by dampening FGF signalling. It has previously been reported that premature cadherin switching 
results in gross morphological and cell-fate allocation defects at gastrulation, resulting at least in 
part from defects in extra-embryonic tissues (Basilicata et al., 2016). Our findings suggest that there 
may also be a cell-autonomous requirement for cadherin switching during neural differentiation. 
 E-cadherin is required to initiate differentiation in some contexts (Pieters et al., 2016), but 
once differentiation is triggered cadherins can have positive or negative effects on subsequent 
lineage specification (Pieters et al., 2016; Takehara et al., 2015), highlighting the multiple stage-
specific effects of cadherins during differentiation of pluripotent cells. Our experiments focus on 
neural differentiation and so our data do not exclude the possibility that N-cadherin modulates 
differentiation into other lineages. 
 Our findings confirm previous reports that the absence of E-cadherin can limit the pool of 
nuclear beta catenin (Hendriksen et al., 2008; Orsulic et al., 1999; Wetering et al., 2001), but we find 
that this does not result in a dampening the transcriptional response to Wnt in differentiating neural 
progenitors: this is in keeping with similar findings in some cell types (Hendriksen et al., 2008; Orsulic 
et al., 1999; Wetering et al., 2001), but contrasts with findings in other contexts where changes in E-
cadherin do modulate the transcriptional response to Wnt (Howard et al., 2011; Libusova et al., 
2010). Nevertheless, cadherin switching enables cells to resist the anti-neural effects of Wnt, 
possibly through an indirect mechanism. It would be interesting to explore the positional identity 
and potency of the Sox1+ cells that emerge in the presence of exogenous Wnt and N-cadherin, given 
that Sox1 is expressed in neuromesodermal progenitors (Cambray and Wilson, 2007) and that Wnt 
helps support neuromesodermal progenitor identity in the posterior of the embryo (Takemoto et al., 
2005; Turner et al., 2014).  
 We find that N-cadherin can dampen FGF activity, leading us to speculate that N-cadherin 
might contribute to reinforcing neural commitment by protecting early neural cells from fluctuations 
in the anti-neural pro-mesoderm FGF signal. Because N-cadherin on one cell will stabilise N-cadherin 
on neighbouring cells through homotypic interaction, it is tempting to speculate that N-cadherin 
helps to propagate this neural-stabilisation effect through the tissue via a type of 'community effect'. 
This could help ensure that neural commitment proceeds robustly in the embryo. It has recently 
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been proposed that cadherins propagate mesodermal differentiation from cell to cell in an in vitro 
model of the primitive streak, although in that case communication is propagated predominantly 
through changes in E-cadherin rather than N-cadherin (Martyn et al., 2018). Differentiation is more 
variable and unpredictable in culture compared to the embryo, even though the extrinsic signalling 
environment in a culture dish can be tightly controlled. We speculate that a cadherin-mediated 
community effect may operate less efficiently in culture where the earliest N-cadherin positive cells 
will often encounter neighbours that lack N-cadherin. 
 This work highlights the importance of changes in adhesion and morphology in ensuring 
robust development, and suggests that efforts to mimic these changes in culture will be critical for 
gaining full control over differentiation of pluripotent cells.  
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Materials & Methods 
Mouse ES cell culture 
Naïve stem cell culture (2i-Lif): naïve ES cells were maintained in 2i-Lif medium (Ying et al., 2008). 
This medium is N2B27 supplemented with 1µM PD0325901, 3µM Chiron 99021 and 100 units/mL LIF 
on laminin-coated tissue culture plates. Naïve stem cells were derived by passaging LIF-serum-
cultured ES cells into 2i-Lif conditions, and maintaining them for at least three passages. LIF-serum 
culture: ES cells were maintained in GMEM supplemented with 2-mercaptoethanol, non-essential 
amino acids, glutamine, pyruvate, 10% foetal calf serum (FCS) and 100 units/mL LIF on gelatinised 
tissue culture flasks (Smith, 1991). Epiblast stem cell culture: EpiSCs were maintained under in 
published conditions (Brons et al., 2007; Tesar et al., 2007). Briefly, the cells were maintained in 
N2B27 solution supplemented with 20ng/mL Activin and 10ng/mL FGF on fibronectin-coated tissue 
D
ev
el
o
pm
en
t •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
culture plates. EpiSCs were derived by passaging LIF-serum-cultured ES cells into EpiSC conditions, 
and maintaining them for at least three passages.  
Cell lines 
E14tg2α mouse embryonic stem cells were used as WT cells. Previously published cell lines were 
generously provided by the researchers and labs who generated them: Sox1-GFP (“46C”) cells, 
(Aubert et al., 2003); EcadNcad/Ncad cells (Basilicata et al., 2016; Kan et al., 2007) that were targeted to 
an E14.1 background, and chimeric mice were then backcrossed to C57BL/6 for at least 3-4 
generations before homozygous EcadNcad/Ncad ES cells were established from blastocysts; Ecad-/- cells 
on an E14-IB10 background, in which exons 4 to 15 were Cre-excised in vitro (Derksen et al., 2006; 
Pieters et al., 2016).  
To generate Dox-inducible N-cadherin overexpressing ES cells, the inducible cassette exchange (ICE) 
method was used (Iacovino et al., 2011; Iacovino et al., 2014). Primers were designed to allow for 
the amplification of a DNA fragment containing the Cdh2 gene C-terminally tagged with an influenza 
virus hemagglutinin (HA) tag; the whole construct was flanked by XhoI and NotI restriction sites. The 
construct was ligated into a pCR Blunt II Topo vector (Thermo Fisher Scientific). The Cdh2-HA insert 
was then ligated into a p2Lox-eGFP plasmid, replacing an eGFP sequence in this construct (Iacovino 
et al., 2009). The resulting p2Lox-Cdh2-HA plasmid was then nucleofected into A2LoxCre cells. The 
cells were then cultured for 10 days under G418 selection, and surviving clonal colonies were then 
expanded. Clones were then screened for Ncad and HA expression by ICC, and three clones with high 
transgene expression were selected for use in further experiments.  
All cell lines used in this study were tested to confirm the absence of mycoplama contamination. 
Differentiation protocols 
Monolayer neural differentiation was performed by passaging 2i-Lif-cultured ES cells at low density 
into laminin-coated tissue culture plates. The cells were maintained in 2i-Lif for 24h to allow the cells 
to properly adhere to the matrix. After 24h, media were changed to N2B27 medium in which 
commercial N2 was replaced with 0.5% modified N2 (made in-house as described in Pollard et al., 
2006). Media were changed every 1-2 days.  
qRT-PCR 
Primers used for qRT-PCR are described in Supplementary table S1. All expression values were 
normalised to the geometric mean expression value of at least two of three housekeeping genes: 
TBP, SDHA, and Ywhaz.  
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RPPA analysis 
 
RPPA analysis was performed on nitrocellulose coated slides as previously described (Macleod et al., 
2017). Briefly, cells were washed with PBS and lysed in 1% Triton X-100, 50 mM HEPES (pH 7.4), 150 
mM sodium chloride, 1.5 mM magnesium chloride, 1 mM EGTA, 100 mM sodium fluoride, 10 mM 
sodium pyrophosphate, 1 mM sodium vanadate, 10% glycerol, supplemented with cOmplete ULTRA 
protease inhibitor and PhosSTOP phosphatase inhibitor cocktails (Roche). Cleared lysates were 
serially diluted to produce a four step doubling dilution series of each sample, which were spotted in 
technical triplicate onto nitrocellulose-coated slides (Grace Bio-Labs) under conditions of constant 
70% humidity using an Aushon 2470 array platform (Aushon Biosystems). After hydration slides were 
blocked using SuperBlock (TBS) blocking buffer (Thermo Fisher Scientific) and incubated with 
validated primary antibodies (all diluted 1:250 in SuperBlock; Supplementary table S2). Bound 
antibodies were detected by incubation with anti-rabbit DyLight 800-conjugated secondary antibody 
(New England BioLabs). Slides were analysed using an InnoScan 710-IR scanner (Innopsys), and 
images were acquired at the highest gain without saturation of the fluorescence signal. The relative 
fluorescence intensity of each array feature was quantified using Mapix software (Innopsys).  
Primary antibodies used in this assay are listed in Supp table S2. In the case of the Sox1 antibody, we 
determined that this antibody does not cross-react with Sox2 based on a lack of signal in 
undifferentiated ES cells bue we cannot exclude cross-reactivity with other Sox family members.  The 
linear fit of the dilution series of each sample was determined for each primary antibody, from 
which median relative fluorescence intensities (RFI) values were calculated to provide relative 
quantification of total protein and phosphoprotein abundance across the sample set. Finally, signal 
intensities were normalized to total protein loading for each sample by using readout from a fast-
green (total protein) stained array slide. Enrichment values for EcKO and NcKI cells were normalised 
to those in relevant control cell lines, and a mean enrichment was then calculated for three 
biological replicates.  
Statistical analysis 
All experiments that were statistically analysed were performed with at least three independent 
biological replicates. Statistical significance was calculated using a paired or unpaired Student’s t-test 
as appropriate.  
Immunofluorescence, FACS 
For immunofluorescence analysis, cells cultured on glass coverslips were fixed in 4% formaldehyde 
and incubated for at least 30 min in blocking buffer (PBS, 3% donkey serum and 0.1% Triton). 
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Primary antibodies were diluted in blocking buffer and applied for 1 hr at room temperature or 
overnight at 4°C. After three washes in PBS, secondary antibodies conjugated to Alexa fluorophores 
(Life Technologies) were diluted at 1:1000 in blocking buffer and applied for 1 hr at room 
temperature. The cells were washed at least three times and the coverslips were mounted with 
Prolong Gold Antifade Reagent (Life Technologies) on glass slides for viewing.  
For antibody staining of live cells for flow cytometry, cells were incubated with relevant antibodies 
on ice in the dark for at least 15 minutes. Antibodies were diluted in FACS buffer (5% FCS in PBS). 
Flow cytometric analysis was performed using a BD Accuri flow cytometer. FACS was carried out on a 
FACS Aria cell sorter.  
Embryos were fixed with 4% formaldehyde/PBS/0.1% Triton X-100 (Sigma) for 30 minutes, and 
quenched with 50mM ammonium chloride. Cellular permeabilization was carried out for 10 min in 
PBS/0.1% Triton X-100. The embryos were incubated in primary antibody in 3% donkey 
serum/PBS/0.1% Triton X-100 overnight, and subjected to 3 washes in PBS/0.1% Triton X-100. 
Secondary antibodies were applied subsequently for 2h to overnight, followed by 3 washes in 
PBS/0.1% Triton X-100. Embryos were then stained with DAPI (Biotium), mounted in PBS droplets 
covered with mineral oil in “microscope rings”, and imaged on a Leica SP8 confocal microscope. 
Alternatively, following staining, chimaeric embryos requiring immunostaining quantification were 
dehydrated in methanol series in PBS/0.1% Triton X-100, clarified in 50% methanol/50% BABB 
(benzyl alcohol:benzyl benzoate 1:2 ratio, Alfa Aesar and Sigma), transferred into 100% BABB in glass 
capillaries and imaged on a Leica SP8 confocal microscope. 
Animal Care and Use 
Animal experiments (mus musculus MF1) were performed under the UK Home Office project license 
PEEC9E359, approved by the Animal Welfare and Ethical Review Panel of the University of Edinburgh 
and within the conditions of the Animals (Scientific Procedures) Act 1986. The sex of embryos used 
in this study was not determined.  
Transcript enrichment analysis 
Gene enrichment datasets generated by Nanostring were analysed using the associated NSolver 4.0 
software. Functional annotation of gene lists was performed using the DAVID functional annotation 
online tool (Huang et al., 2008; Huang et al., 2009). A list of significantly changing genes was used as 
an input list, while all 770 genes tested in the Nanostring analysis (Supp Table S4) were used as a 
background list.  
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Quantitative image analysis 
Quantification of membrane-bound protein staining: where fluorescent signal was to be quantified 
at the single-cell level, cells were imaged in 3D Z-stacks on a Leica SP8 three-detector confocal 
microscope. For the quantification of membrane staining, cells were counted manually using 
Fiji/ImageJ software. Quantification of nuclear protein staining: for the quantification of nuclear 
staining, PickCells software was used. Cells were segmented by nuclear content or nuclear 
membrane staining (using DAPI or nuclear envelope marker LaminB1 staining, respectively) using the 
software’s inbuilt NESSys nuclear segmentation module (Blin et al., 2019). Protein expression was 
then quantified as the mean pixel intensity in any given nucleus. Where staining quality did not allow 
for accurate nuclear segmentation, cells were manually designated as either positive or negative 
based on a single empirical threshold for all images generated from a single biological replicate. 
Quantification of inter-nuclear edge distances: inter-nuclear edge distance was calculated using 
PickCells software in cells segmented using nuclear membrane staining. The nearest neighbours for 
each nucleus were determined using Delaunay triangulation, and the distance between the 
membranes of nearest neighbours was calculated for each nucleus up to a distance of 40 microns.  
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 Figures 
 
 
 
 
Figure 1: Cadherin switching precedes the loss of pluripotency marker expression and coincides 
with neural priming in vitro.  
A. Cells cultured in three pluripotent conditions stained for E-cadherin, N-cadherin, and the nuclear 
envelope marker LaminB1. B. qRT-PCR analysis of E-cadherin expression in cells cultured in three 
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pluripotent conditions, N=3. C. Flow cytometric analysis of E- and N-cadherin expression in cells 
cultured in various pluripotent conditions; curves show representative sample of three biological 
replicates. D. Example ICC image of EpiSCs stained Ecad, Ncad, Oct4 and LaminB1 E. Quantification 
of protein co-expression in EpiSCs. N=2596 cells from three biological replicates. F. Sorting and 
analysis strategy for EpiSCs heterogeneously expressing E-cadherin. G. Example FACS gating of 
EpiSCs into three populations based on their level of E-cadherin expression; each population makes 
up ~20% of live cells. H. qPCR analysis of sorted EpiSC populations. EcadLow and EcadHigh populations 
were normalised to the EcadMed population. N=3 independent sorts. I. Example ICC image of Sox1-
GFP (46C) cells undergoing neural differentiation stained for Ecad, Ncad, Sox1 and Lamin1. J. 
Quantification of protein co-expression in Sox1-GFP cells undergoing neural differentiation. N=2275 
cells from three biological replicates. Error bars=SD, *p≤0.05, **p≤0.01, paired T-test. All images 
shown to same scale, scale bars=50um. 
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Figure 2: N-cadherin promotes neural differentiation.  
A. Cadherin expression in four cell lines used for cadherin domain deletion/substitution 
experiments. Cells cultured in neural differentiation conditions for 24h. LaminB1: nuclear envelope 
marker. B. qPCR analysis of above cell lines during successive days of neural differentiation. N=3. 
Values normalised to control cell line on D0. C. Representative images showing expression of the 
early neural marker Sox1 in above cells after 3-4 days of neural differentiation.  D. Quantification of 
Sox1 expression in the above cells during neural differentiation. N=9, three fields of view from three 
biological replicates.  E. ICC of inducible N-cadherin overexpressing cells cultured in neural 
differentiation conditions for 24h with or without Dox. F. Protocol for neural differentiation of 
inducible N-cadherin overexpressing cells. Triangles indicate sample collection. G. qPCR analysis of 
inducible N-cadherin overexpressing cells during neural differentiation; Dox added on day 2. N=9 
(three biological replicates of three independent clones). Error bars=SD, *p≤0.05, **p≤0.01, 
unpaired T-test. All scale bars=50µm. 
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Figure 3: Effects of cadherin switching on cellular clustering.  
A. Methodology for measuring inter-nuclear edge distances. For each nucleus (white solid line), the 
nearest neighbours (grey solid line) within a 40µm radius (white dashed line) are determined by 
Delaunay triangulation, and the inter-nuclear edge distances between these nuclei are calculated; 
the process is repeated for all nuclei in the image. Scale bar=50um. B. ICC of all cell lines used for 
cadherin domain deletion/substitution experiments stained for LaminB1. Ncad overexpression was 
performed in A2Lox-Ncad-HA cells. Cells cultured in neural differentiation conditions for 24h, scale 
bar=50um. C. Density plots of inter-nuclear edge distance in four cell lines. N=1054 for all samples, 
plots show a representative sample for three biological replicates.  D. Mean inter-nuclear edge 
distances. N=3 biological replicates, each containing 100-1000s of cells. E. Mean cell number. N=3 
biological replicates. Error bars=SD, *p≤0.05, **p≤0.01, paired T-test.  
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Figure 4: Effects of cadherin switching on β-catenin and WNT signalling  
A. Heatmap showing enrichment of protein and phospho-protein species in Ecad-/-  and EcadNcad/Ncad 
cells compared to control cell lines; all cells were cultured in neural differentiation conditions for 24h 
at time of analysis. Data generated by RPPA, N=3. B. Example confocal images of cells at 24h of 
neural differentiation cultured in varying Wnt3a concentration and stained for un-phosphorylated β-
catenin. Scale bar=50µm. C. Quantitative visualisations of nuclear staining of images shown in (B). D. 
Quantification of mean nuclear voxel intensity for un-phosphorylated β-catenin in cells cultured for 
24h in neural differentiation conditions. N=4 biological replicates, each containing 100s of cells. E, F. 
Example images (E) of Sox1 expression in cells cultured with or without Wnt3a. “High Wnt3a” refers 
to 100ng/mL. Dot plots (F) show quantification of percentage of Sox1-positive cells; each dot 
represents one field of view; N=9, three images each sampled from three biological replicates. G. 
qPCR analysis of two Wnt pathway readouts in Ecad-/-  and EcadNcad/Ncad cells during neural 
differentiation in increasing concentrations of Wnt3a. N=3 biological replicates. For all graphs, error 
bars=SD, *p≤0.05, **p≤0.01, ***p ≤ 0.001; unpaired T-test. 
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Figure 5: Cadherin switching promotes neural differentiation by dampening FGF signalling.  
A. Top five signalling pathways most affected by N-cadherin overexpression 48 post-induction 
compared to un-induced control. Data generated by DAVID functional annotation of Nanostring 
mRNA expression values. 142 genes out of 770 genes tested changed significantly. B. Protocol for 
FGF modulation experiments in inducible N-cadherin overexpressing cell lines. C. qPCR analysis in 
WT cells with FGF2 or PD17. N=3 biological replicates, error bars=SE *p≤0.05, **p≤0.01 compared to 
untreated control, unpaired T-test. D. qPCR analysis of gene expression after 48h of N-cadherin 
induction. N=9, error bars=SD, *p≤0.05, **p≤0.01, unpaired T-test. N.s.= no significance. 
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Figure 6: Cadherin switching and neural differentiation are more synchronous in vivo than in vitro.  
A. E- and N-cadherin co-expression in the E7.5 mouse embryo, sagittal view. Meso: mesoderm; NE: 
neuroectoderm; Epi: epiblast. B. A region of Sox1+ neuroectoderm (NE) adjacent to Sox-negative 
mesoderm (Meso) and endoderm (Endo) is shown from an E7.5 embryo. Nuclei stained with DAPI. C. 
Nuclear segmentation and binning of cells shown in (B): cells are assigned as belonging to the 
neuroectoderm layer (green) or non-neurectoderm layers (blue) Unassigned cells are shown in 
yellow.  D. Sox1 expression at day 3 of neural differentiation in vitro. Nuclei stained with nuclear 
envelope marker LaminB1. E. Quantitative analysis of Sox1 expression in neural and non-neural 
tissues of the anterior E7.5 embryo. N=438 nuclei per sample. F. Quantitative analysis of Sox1 
expression at day 3 of neural differentiation in vitro, cultured with and without the neural 
differentiation inhibitor Wnt3a. N=231 nuclei per sample. In F-G, percentages refer to the proportion 
of Sox1-positive cells in the neural sample (red line; negative control population in black) as 
calculated by the non-overlapping area under the two curves. All scale bars=50µm. 
 
 
D
ev
el
o
pm
en
t •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
Table 1: Significant changes in gene expression 48h after N-cadherin overexpression during neural differentiation. Cells were cultured for 48h in neural 
differentiation conditions when N-cadherin overexpression was induced by addition of Dox. RNA samples were collected for Nanostring gene expression 
analysis 48h later. The analysis included 770 genes involves in cellular signalling pathways. Values show mean enrichment compared to un-induced controls. 
N=3 biological replicates.  
Significantly downregulated genes Significantly upregulated genes 
      Gene Mean enrichment.  Gene Mean enrichment.  
Il6 0.25 
 
Hprt 12.34 
 Il20ra 0.25 
 
Hes5 2.41 
 Pla2g4e 0.26 
 
Pax3 2.29 
 Fgf21 0.33 
 
Pitx2 1.62 
 Rasgrp1 0.37 
 
Fzd10 1.6 
 Dusp4 0.37 
 
Jag1 1.49 
 Lamc3 0.39 
 
Notch3 1.38 
 Rasal1 0.39 
 
Fgfr2 1.3 
 Sfrp4 0.39 
 
Fubp1 1.26 
 Tnfsf10 0.41 
 
Ccne1 1.26 
 Gdf6 0.43 
 
Brca1 1.18 
 Cxcl5 0.44 
 
Phf6 1.16 
 Jag2 0.48 
 
U2af1 1.1 
 Pik3cd 0.5 
    Wnt11 0.5 
    Itgb3 0.51 
    Irak2 0.52 
    Crlf2 0.53 
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Spp1 0.53 
    Fgf14 0.53 
    Map3k1 0.54 
    Hdac11 0.54 
    Fosl1 0.54 
    Kat2b 0.55 
    Fgf6 0.55 
    Lep 0.55 
    Ntrk1 0.56 
    Prkcb 0.56 
    Pla2g4a 0.56 
    Syk 0.56 
    B2m 0.56 
    Cblc 0.57 
    Pml 0.57 
    Nos3 0.57 
    Shc2 0.58 
    Nfkbia 0.58 
    Efna1 0.58 
    Il11ra2 0.58 
    Chad 0.59 
    Rasgrp2 0.6 
    Tlr2 0.6 
    Cebpa 0.6 
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Birc7 0.6 
    Pgf 0.6 
    Ptch1 0.6 
    Dkk4 0.61 
    Sgk2 0.62 
    Birc3 0.62 
    Pim1 0.62 
    Hspa2 0.62 
    Efna3 0.63 
    Tet2 0.64 
    Tsc1 0.64 
    Etv4 0.65 
    Plcb1 0.66 
    Cacng1 0.66 
    Il3ra 0.67 
    Figf 0.67 
    Stat3 0.68 
    Mfng 0.68 
    Nfe2l2 0.68 
    Itga9 0.69 
    Runx1t1 0.7 
    Tlx1 0.7 
    Hdac5 0.71 
    Ubb 0.72 
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Cacna1 0.72 
    Insr 0.73 
    Cdh1 0.73 
    Fzd8 0.74 
    Fancl 0.74 
    Alas1 0.74 
    Rpl19 0.75 
    Kit 0.75 
    Ar 0.75 
    Prkx 0.75 
    Xrcc4 0.75 
    Vegfb 0.76 
    Ppp2cb 0.76 
    Ppp3ca 0.76 
    Camk2b 0.76 
    Dtx3 0.76 
    Alkbh2 0.76 
    Reln 0.77 
    Fn1 0.77 
    Bnip3 0.77 
    Ep300 0.77 
    Polr2j 0.78 
    Fgf13 0.78 
    NEG_B 0.78 
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Hist1h3b 0.79 
    Pik3ca 0.79 
    Tspan7 0.79 
    Stag2 0.79 
    Acvr1b 0.79 
    Shc1 0.79 
    Whsc1l1 0.79 
    Cacna1 0.79 
    Edc3 0.8 
    Bax 0.81 
    Uty 0.81 
    Tsc2 0.81 
    Mgmt 0.81 
    Ercc6 0.83 
    Ppp2r2b 0.83 
    Npm1 0.83 
    Braf 0.83 
    Cdc14b 0.83 
    Kdm6a 0.84 
    Hdac3 0.84 
    Foxo4 0.85 
    Eef1g 0.86 
    Ercc3 0.86 
    Med12 0.87 
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Sdha 0.87 
    Stmn1 0.87 
    Crebbp 0.88 
    Gsk3b 0.88 
    Rad21 0.88 
    Notch1 0.89 
    Traf7 0.9 
    Chuk 0.9 
    Fanca 0.91 
    Prkaca 0.91 
    Prkaa2 0.91 
    Mapk9 0.92 
    Endog 0.92 
    Prkar2a 0.92 
    Ppp2r1a 0.95 
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Figure S1: Single-cell views of protein co-expression in EpiSCs and during neural differenBaBon.
White	  arrowheads	  point	  out	  individual	  cells	  of	  the	  given	  protein	  expression	  profile. Percentages 
below	 images	 indicate	 the	 propor;on	 of	 cells	 of	 a	 given	 iden;ty	 out	 of	 all	 cells	 analysed 
(manual	quan;fica;on).	Scale	bars=25µm.	A.	EpiSCs	stained	for	E-cadherin	(green),	N-cadherin	(red),	
the	 pluripotency	marker	Oct4	(white)	and	nuclear	envelope	marker	LaminB1	(blue).	N=2596	ce
lls	from	three	 biological	replicates	B.	Cells	on	day	four	of	neural	differen;a;on	from	a	2i-Lif	s
tar;ng	popula;on	stained	 for	E-cadherin	(green),	N-cadherin	(red),	Sox1-GFP	(shown	in	white), 
and	nuclear	envelope	marker	LaminB1	 (blue).	N=2275	cells	from	three	biological	replicates.		
A	
B	
Development: doi:10.1242/dev.183269: Supplementary information
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Figure	S2:	Cadherin	switching		has	no	clear	effect	on	mesoderm	or	endoderm	markers	in	the	context	of	
neural	differenBaBon
A:	qPCR	analysis	of	EcadhNcadh/Ncadh	cells		during	successive	days	of	neural	differen;a;on.	N=3.	Values
normalised	to	control	cell	line	on	D0.	
B:		qPCR	analysis	of	inducible	N-cadherin	overexpressing	cells	during	neural	differen;a;on;	Dox	added	on	
day	2.	N=9	(three	biological	replicates	of	three	independent	clones).	Values	normalised	to	control	cell	line
on	D0	
Error	bars=SD.	
Development: doi:10.1242/dev.183269: Supplementary information
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Figure	 S3:	 Ecad-/-	cells	die	a[er	prolonged	culture	in	N2B27.	  	  Phase	 contrast	 images	 of	 EcadFlox/Flox	
and	Ecad-/-	cells	on	days	2-6	of	neural	differen;a;on	from	a	2i-Lif	star;ng	popula;on.	Scalebar=	 100µm.		
Development: doi:10.1242/dev.183269: Supplementary information
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Figure	S4:	Effects	of	cadherin	switching	on	β-catenin	and	WNT	signalling.	qPCR	analysis	of	EcadFlox/Flox	an
d	EcadNcad/Ncad	cells	during	neural	differen;a;on	in	increasing	concentra;ons	of	Wnt3a;	bars	 denote	 mean	 
expression	 rela;ve	 to	 the	 Day	 1	 condi;on	 of	 the	 relevant	 control	 cell	 line	 (grey).	 Asterisks	denote
	significant	difference	compared	to	the	paired	control	cell	line	in	the	same	condi;on.	N=3	biological	 
replicates.	Error	bars=SD,	*p≤0.05,	**p≤0.01,	paired	T-test.		
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Target	gene	 Forward	sequence	 Reverse	sequence	 UPL	probe	number	
Ap2a	 CCGGGTATTAACATCCCAGAT	 CCGAAGAGGTTGTCCTTGTTA	 94	
Axin2	 TGGGGAGCAGTTTTGTGC	 CGGCTGACTCGTTCTCCT	 96	
Cdh1	 ATCCTCGCCCTGCTGATT	 ACCACCGTTCTCCTCCGTA	 18	
Cdh2	 GCCATCATCGCTATCCTTCT	 CCGTTTCATCCATACCACAAA	 18	
Dusp4	 GCCTGGCCTACCTGATGAT	 GCTGCTTGACGAACTCAAAA	 25	
Etv4	 GGGTACCTTGGTGAGCACAG	 CCCTGAGGAGATGTGAAGGA	 66	
Nanog	 CCTCCAGCAGATGCAAGAA	 GCTTGCACTTCATCCTTTGG	 25	
Pax3	 AAAAGGCTAAACACAGCATCG	 CAATATCGGAGCCTTCATCTG	 110	
Pax6	 GTTCCCTGTCCTGTGGACTC	 ACCGCCCTTGGTTAAAGTCT	 78	
Pou3f1	 CTCAAGCCGCTGCTCAAC	 CGCGATCTTGTCCAGGTT	 25	
Pou5f1	 GTTGGAGAAGGTGGAACCAA	 CTCCTTCTGCAGGGCTTTC	 95	
SDHA	 CAGTTCCACCCCACAGGTA	 TCTCCACGACACCCTTCTGT	 71	
Sox1	 GTGACATCTGCCCCCATC	 GAGGCCAGTCTGGTGTCAG	 60	
Sox17	 CACAACGCAGAGCTAAGCAA	 CGCTTCTCTGCCAAGGTC	 97	
T	 ACTGGTCTAGCCTCGGAGTG	 TTGCTCACAGACCAGAGACTG	 27	
TBP	 GGGGAGCTGTGATGTGAAGT	 CCAGGAAATAATTCTGGCTCA	 97	
Ywhaz	 TTACTTGGCCGAGGTTGCT	 TGCTGTGACTGGTCCACAAT	 9	
Table	S1:	qPCR	primer	sequences.		
Primers	used	with	the	Universal	Probe	Library	qPCR	system	from	Roche.	
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Table	S2:	RPPA	anBbodies	
All	an;bodies	were	raised	in	rabbit		
	Epitope		 Supplier Catalogue	no.
Akt Cell	Signaling	Technologies 9272
Akt	P	Ser473 Cell	Signaling	Technologies 4060
Akt	P	Thr308 Cell	Signaling	Technologies 2965
beta-actin Cell	Signaling	Technologies 4970
beta-Catenin Cell	Signaling	Technologies 9562
beta-Catenin	P	Ser33,Ser37,Thr41 Cell	Signaling	Technologies 9561
beta-Catenin	P	Thr41,Ser45 Cell	Signaling	Technologies 9565
Caspase	3 Cell	Signaling	Technologies 9662
Caspase	3	cleaved Cell	Signaling	Technologies 9664
c-Jun	N-term Epitomics 1254-1
c-Jun	P	Ser73 Cell	Signaling	Technologies 9164
E-Cadherin Cell	Signaling	Technologies 3195
GSK-3-alpha/beta	P	Ser21/Ser9 Cell	Signaling	Technologies 9331
GSK-3-beta Cell	Signaling	Technologies 9315
GSK-3-beta	P	Ser9 Cell	Signaling	Technologies 9336
IGF-1R	beta Cell	Signaling	Technologies 3027
ILK1	(4G9) Cell	Signaling	Technologies 3856
Integrin	alpha	4 Cell	Signaling	Technologies 4600
Integrin	Beta	1	[EP1041Y] Abcam ab52971
Integrin	beta3 Cell	Signaling	Technologies 4702
Integrin	beta4 Cell	Signaling	Technologies 4707
IRS-1 Cell	Signaling	Technologies 2382
JAK1 Cell	Signaling	Technologies 3332
JAK1	P	Tyr1022,Thr1023 Invitrogen	(Biosource) 44-422G
MAPKAPK-2 Epitomics 1497-1
MAPKAPK-2	P	Thr334 Cell	Signaling	Technologies 3041
MEK1/2 Cell	Signaling	Technologies 9122
MEK1/2	P	Ser217/221 Cell	Signaling	Technologies 9154
MEK6	[EP558Y] Abcam ab52937
mTOR Cell	Signaling	Technologies 2972
mTOR	P	Ser2448 Cell	Signaling	Technologies 2971
NFkB	p105/p50 Calbiochem GTX110585
NFkB	p65	Ser536 Cell	Signaling	Technologies 3033
p38	MAPK Cell	Signaling	Technologies 9212
p38	MAPK	PThr180,Tyr182 Cell	Signaling	Technologies 9211
p44/42	MAPK	(ERK1/2) Cell	Signaling	Technologies 9102
p44/42	MAPK	(ERK1/2)	P	
Thr202/Thr185,Tyr204/Tyr187
Cell	Signaling	Technologies 4370
p90	S6	kinase	(Rsk1-3) Santa	Cruz sc-231
PDK-1 Cell	Signaling	Technologies 3062
PDK-1	P	Ser241 Cell	Signaling	Technologies 3061
PKA Abcam ab26322
Prohibitin Santa	Cruz sc-28259
Raf	P	Ser338 Cell	Signaling	Technologies 9427
Rsk2	Pser	227 Cell	Signaling	Technologies 3556
Slug	(C19G7 Cell	Signaling	Technologies 9585
Smad1/5	P	Ser463/Ser465 Cell	Signaling	Technologies 9516
Smad2	P	Ser465,Ser467 Cell	Signaling	Technologies 3108
Smad2/3	P	Ser465/Ser423,Ser467/Ser425 Cell	Signaling	Technologies 8828
Smad3	P	Ser423,Ser425 Cell	Signaling	Technologies 9520
Stat3 Cell	Signaling	Technologies 12640
Stat3	P	Y705 Cell	Signaling	Technologies 9131
Stat5 Invitrogen	(Biosource) 44-368G
Stat5	P	Tyr694 Cell	Signaling	Technologies 9351
Stat6 Cell	Signaling	Technologies 9362
Stat6	P	Tyr641 Cell	Signaling	Technologies 9361
Tsc-2	(Tuberin) Cell	Signaling	Technologies 3612
Tsc-2	(Tuberin)	P	Thr1462 Cell	Signaling	Technologies 3617
YAP	P	Ser127 Cell	Signaling	Technologies 4911
YAP1	[EP1674Y] Abcam ab52771
Zyxin Cell	Signaling	Technologies 3553
Development: doi:10.1242/dev.183269: Supplementary information
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Table	S3:	Immunocytochemistry	and	flow	cytometry	an;bodies
All	an;bodies	were	diluted	to	the	specified	concentra;on	in	blocking	buffer.		
	
	
Epitope	recognised	 Clone	 Host	
species	
Dilution	
factor	
Supplier	 Cat.	
number	
β-catenin	(active),	
dephosphorylated	on	
Ser37	or	Thr41	
8E7	 Mouse	 1:1000	 Millipore	 05-665	
E-cadherin	 DECMA-1	 Rat	 1:200	 Sigma	 U3254	
E-cadherin,	eFluor660-
conjugated	
DECMA-1	 Rat	 1:300	 eBioscience	 50-3249-
82	
GFP	 Polyclonal	 Chicken	 1:1000	 Abcam	 13970	
HA	 HA-7	 Mouse	 1:1000	 Sigma	 H3663	
Laminβ1	 Polyclonal	 Chicken	 1:1000	 Abcam	 Ab90169	
Laminβ1	 Polyclonal	 Rabbit	 1:1000	 Abcam	 Ab16048	
N-cadherin	 32	 Mouse	 1:200	 BD	 610920	
N-cadherin,	AlexaFluor488-
conjugated	
Polyclonal	 Sheep	 1:50	 R&D	 FAB6426G	
Oct4	 N-19	 Goat	 1:200	 Santa	Cruz	 SC-8628	
Sox1	 N23-844	 Mouse	 1:200	 Pharmigen	 560749	
1
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